Left ventricular end diastolic pressure and acute coronary syndromes
Rogério Teixeira1, Carolina Lourenço, Rui Baptista
1Departamento de Cardiologia, Hospital Universitário, Faculdade de Medicina de Coimbra, Portugal. rogeriopteixeira@gmail.com
Insights
Elevated left ventricular-end diastolic pressure (LVEDP) in acute coronary syndromes (ACS) predicts higher mortality and heart failure readmissions. Lower LVEDP is associated with better one-year survival in ACS patients.
Area of Science:
- Cardiology
- Cardiovascular Research
- Clinical Medicine
Background:
- Limited data exists on the prognostic significance of left ventricular-end diastolic pressure (LVEDP) in acute coronary syndromes (ACS).
- Understanding LVEDP's role is crucial for risk stratification and management of ACS patients.
Purpose of the Study:
- To evaluate the prognostic impact of LVEDP in patients experiencing acute coronary syndromes.
- To determine if LVEDP can predict mortality and future hospitalizations in ACS.
Main Methods:
- A prospective study of 1329 ACS patients was conducted.
- Patients were categorized based on LVEDP: < 26.5 mmHg (Group A) and ≥ 26.5 mmHg (Group B).
- One-year survival and readmission rates for heart failure were analyzed.
Main Results:
- A LVEDP ≥ 26.5 mmHg was an independent predictor of one-year mortality (HR 2.45).
- Elevated LVEDP also independently predicted future readmission for congestive heart failure (HR 6.65).
- One-year survival was significantly higher in patients with lower LVEDP (Group A).
Conclusions:
- Left ventricular-end diastolic pressure demonstrates significant prognostic value in acute coronary syndrome patients.
- Higher LVEDP is associated with increased risk of mortality and heart failure readmission.
- LVEDP measurement can aid in identifying high-risk ACS individuals.
Background:
Data is lacking in the literature regarding the prognostic impact of left ventricular-end diastolic pressure (LVEDP) across acute coronary syndromes (ACS).
Objective:
To assess LVEDP and its prognostic implications in ACS patients.
Methods:
Prospective, longitudinal and continuous study of 1329 ACS patients from a single center between 2004 and 2006. Diastolic function was determined by LVEDP. Population was divided in two groups: A - LVEDP < 26.5 mmHg (n = 449); group B - LVEDP ≥ 26.5 mmHg (n = 226).
Results:
There were no significant differences between groups with respect to risk factors for cardiovascular disease, medical history and medical therapy during admission. In group A, patients with non-ST elevation ACS were more frequent, as well as normal coronary angiograms. In-hospital mortality was similar between groups, but one-year survival was higher in group A patients (96.9 vs 91.2%, log rank p = 0.002). On a multivariate Cox regression model, a LVEDP ≥ 26.5 mmHg (HR 2.45, 95%CI 1.05 - 5.74) remained an independent predictor for one-year mortality, when adjusted for age, LV systolic ejection fraction, ST elevation ACS, peak troponin, admission glycemia, and diuretics at 24 hours. Also, a LVEDP ≥ 26.5 mmHg was an independent predictor for a future readmission due to congestive HF (HR 6.65 95%CI 1.74 - 25.5).
Conclusion:
In our selected population, LVEDP had a significant prognostic influence.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Mitral Regurgitation I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mitral Stenosis I: Introduction


